In this supplement, learn what strategies some law firms are engaging in to protect the intellectual property many life science firms are bringing forth. We profile some legal leaders and review cases making nationwide headlines.

  • Things your patent attorney should tell you

    A strong patent can form the basis of a successful business. Obtaining a patent can be a daunting process. There are complex rules governing every aspect of the process. Failure to satisfy these rules can result in an unenforceable patent or a patent that is invalidated in litigation.

  • Knobbe Martens Olson & Bear forecasts strong IP growth

    Knobbe Martens Olson & Bear, founded in 1964, is one of the oldest and largest intellectual property law firms in the United States. With more than 160 lawyers and six offices throughout California, Knobbe Martens Olson & Bear is positioned to offer effective, specialized representation in all areas of intellectual property law to clients on a local, national and global level.

  • Fish & Richardson first in biotech and patents

    Realizing the significance that biotechnology would one day have on the United States and throughout the world, Fish & Richardson was one of the first law firms to venture into the field of biotech law. The firm's forward thinking was the foundation for what today is one of the largest biotechnology law practices in the United States and the largest biotechnical and pharmaceutical patent law practice in San Diego.

  • Bad news for biotechs: The government has come to 'help'

    "I'm from the government, and I'm here to help" used to be the punch line to a bad joke. Unfortunately, it's playing again in the Supreme Court's deliberations in the current Merck v. Integra litigation. Now, the U.S. government has weighed in on the case and it may not be bringing help to many San Diego biotechs.

  • Intellectual property: the foundation of your business; the heart of our practice

    At Quinn Emanuel, our intellectual property attorneys are not only technology savvy, they're courtroom-tested veterans.

  • Flower Power: Implications of extraterritorial expansion of 102(b) in plant patent cases

    A German geranium and South African rose may impact the intellectual property rights of inventors in the United States who sell their products abroad before securing U.S. patent rights.

  • Wyeth edges closer to resolving suits over diet drugs

    PHILADELPHIA -- The drug maker Wyeth (NYSE: WYE) is inching closer to resolving lawsuits brought by people who suffered heart damage from taking the fen-phen diet drug combination in the 1990s.

  • Enforcing single-season seeds, Monsanto sues farmers

    SAN FRANCISCO -- Monsanto Co.'s (NYSE: MON) "seed police" snared soy farmer Homan McFarling in 1999, and the company is demanding he pay it hundreds of thousands of dollars for alleged technology piracy.

  • Court agrees to hear patent dispute over cancer therapy

    WASHINGTON -- The Supreme Court agreed to step into a dispute Friday over how far a patent can go to thwart a rival drug company's efforts to conduct research, a question with big-money ramifications in the pharmaceutical industry.

  • Have you got Patential?

    Local patent attorney Richard Warburg has invented a board game that promises to illuminate the drug-development business.

National News